tetradecanoylphorbol acetate and Respiratory Distress Syndrome, Newborn

tetradecanoylphorbol acetate has been researched along with Respiratory Distress Syndrome, Newborn in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Mollenhauer, J; Müller, H; Nagel, C; Poeschl, J; Weiss, C	1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and Respiratory Distress Syndrome, Newborn

Article	Year
Deleted in malignant brain tumors 1 (DMBT1) elicits increased VEGF and decreased IL-6 production in type II lung epithelial cells. BMC pulmonary medicine, 2015, Apr-08, Volume: 15 Topics: Calcium-Binding Proteins; Carcinogens; Case-Control Studies; Cell Line, Tumor; DNA-Binding Proteins; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Humans; In Vitro Techniques; Infant, Newborn; Infant, Premature; Interleukin-6; Lipopolysaccharides; Lung; Receptors, Cell Surface; Respiratory Distress Syndrome, Newborn; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; Tumor Suppressor Proteins; Vascular Endothelial Growth Factor A	2015

Article

Year

Deleted in malignant brain tumors 1 (DMBT1) elicits increased VEGF and decreased IL-6 production in type II lung epithelial cells.

BMC pulmonary medicine, 2015, Apr-08, Volume: 15

Topics: Calcium-Binding Proteins; Carcinogens; Case-Control Studies; Cell Line, Tumor; DNA-Binding Proteins; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Humans; In Vitro Techniques; Infant, Newborn; Infant, Premature; Interleukin-6; Lipopolysaccharides; Lung; Receptors, Cell Surface; Respiratory Distress Syndrome, Newborn; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; Tumor Suppressor Proteins; Vascular Endothelial Growth Factor A

2015